4//SEC Filing
CRUTCHFIELD BRADFORD 4
Accession 0001567619-22-004884
CIK 0001770787other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:48 PM ET
Size
9.1 KB
Accession
0001567619-22-004884
Insider Transaction Report
Form 4
CRUTCHFIELD BRADFORD
Chief Commercial Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-02-15$1.16/sh+17,000$19,720→ 114,653 total - Sale
Class A Common Stock
2022-02-15$95.13/sh−17,000$1,617,261→ 97,653 total - Exercise/Conversion
Stock Option (right to buy)
2022-02-15−17,000→ 392,000 totalExercise: $1.16Exp: 2027-02-03→ Class A Common Stock (17,000 underlying)
Footnotes (3)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $95.00 to $95.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This option, originally for 800,000 shares, of which 408,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Documents
Issuer
10x Genomics, Inc.
CIK 0001770787
Entity typeother
Related Parties
1- filerCIK 0001246406
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:48 PM ET
- Size
- 9.1 KB